Literature DB >> 29280596

The HLA-G 14 bp insertion/deletion polymorphism and its association with soluble HLA-G levels in women with recurrent miscarriages.

V Kalotra1,2, M Lall2, I C Verma2, A Kaur1, A Kaur1.   

Abstract

HLA-G, a nonclassical class-Ib gene is mainly expressed on extravillous trophoblasts at the fetal-maternal interface. HLA-G molecule is considered to play an important role in maternal immune suppression during pregnancy. The 14 bp insertion/deletion polymorphism (rs66554220) in exon eight of the HLA-G gene influences HLA-G mRNA stability and isoform splicing patterns. In this study, 202 recurrent miscarriage (RM) women with two or more than two consecutive miscarriages, their 202 partners and 204 fertile control women with at least one live birth and no miscarriages were analyzed for 14 bp insertion/deletion polymorphism. Soluble HLA-G (sHLA-G) levels were also determined and compared between randomly selected 111 RM women and 111 control women using QAYEE-Bio ELISA kits. Student's t test and χ2 test were used to depict the statistical differences. The results showed no significant differences for 14 bp allele and genotype frequencies between the study groups. However, our study showed a significant difference (P = .0107) for sHLA-G levels in RM women and control women. Furthermore, a significant difference (P = .0135) for sHLA-G levels in relation to +/-14 bp heterozygous genotype was seen between the two groups. The 14 bp allele sharing between the partners did not show any significant association with the number of miscarriages in RM couples. The association of 14 bp polymorphism and recurrent miscarriages was not significant in our study.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  14bp insertion/deletion polymorphism; HLA-G; RMs; sHLA-G

Mesh:

Substances:

Year:  2018        PMID: 29280596     DOI: 10.1111/tan.13198

Source DB:  PubMed          Journal:  HLA        ISSN: 2059-2302            Impact factor:   4.513


  4 in total

1.  Soluble HLA-G Expression Inversely Correlates With Fetal Microchimerism Levels in Peripheral Blood From Women With Scleroderma.

Authors:  Julie Di Cristofaro; Karlin R Karlmark; Sami B Kanaan; Doua F Azzouz; Marina El Haddad; Lucas Hubert; Dominique Farge-Bancel; Brigitte Granel; Jean Robert Harlé; Eric Hachulla; Etienne Pardoux; Jean Roudier; Christophe Picard; Nathalie C Lambert
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561

2.  Increased HLA-G Expression in Term Placenta of Women with a History of Recurrent Miscarriage Despite Their Genetic Predisposition to Decreased HLA-G Levels.

Authors:  Moniek H C Craenmehr; Iris Nederlof; Milo Cao; Jos J M Drabbels; Marijke J Spruyt-Gerritse; Jacqueline D H Anholts; Hanneke M Kapsenberg; Janine A Stegehuis; Carin van der Keur; Esther Fasse; Geert W Haasnoot; Marie-Louise P van der Hoorn; Frans H J Claas; Sebastiaan Heidt; Michael Eikmans
Journal:  Int J Mol Sci       Date:  2019-02-01       Impact factor: 5.923

3.  Molecular Analysis of HLA-G in Women with High-Risk Pregnancy and Their Partners with Regard to Possible Complications.

Authors:  Olimpia Sipak; Aleksandra Rył; Anna Grzywacz; Maria Laszczyńska; Sławomir Szymański; Beata Karakiewicz; Iwona Rotter; Cezary Cybulski
Journal:  Int J Environ Res Public Health       Date:  2019-03-19       Impact factor: 3.390

Review 4.  HLA-G Genotype/Expression/Disease Association Studies: Success, Hurdles, and Perspectives.

Authors:  Giada Amodio; Silvia Gregori
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.